This clinical trial evaluates the impact of synthetic cooling agents in combustible cigarettes on smoking perceptions and use. Menthol, a natural chemical, is a cooling agent that increases nicotine dependence among smokers. Menthol cigarettes largely contribute to the huge burden that smoking puts on public health. Approximately 43% of adult smokers smoke menthol cigarettes. Regulatory agencies have begun a ban on menthol. In response to the ban, the tobacco industry has introduced synthetic cooling agents as a flavorless replacement to provide the same cooling effects as menthol. Information gained from this trial may help researchers determine how the addition of synthetic cooling agents changes the appeal, abuse liability potential, and respiratory toxicity profile of combustible cigarettes.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Cigarette Chemical Contents
Timeframe: Up to end of study, estimated 1 year
Impact of Cooling Effects on Demand via the Forced Choice Task
Timeframe: Up to end of study intervention, up to 3 weeks
Abuse Liability via Puff Topography
Timeframe: Up to end of study intervention, up to 3 weeks
Cigarette Appeal
Timeframe: Up to end of study intervention, up to 3 weeks